CN112724112B - Separation and purification method of stevia rebaudiana - Google Patents
Separation and purification method of stevia rebaudiana Download PDFInfo
- Publication number
- CN112724112B CN112724112B CN202011219059.1A CN202011219059A CN112724112B CN 112724112 B CN112724112 B CN 112724112B CN 202011219059 A CN202011219059 A CN 202011219059A CN 112724112 B CN112724112 B CN 112724112B
- Authority
- CN
- China
- Prior art keywords
- separation
- stevia
- methanol
- compound
- water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 244000228451 Stevia rebaudiana Species 0.000 title claims abstract description 30
- 238000000034 method Methods 0.000 title claims abstract description 30
- 235000006092 Stevia rebaudiana Nutrition 0.000 title claims abstract description 29
- 238000000926 separation method Methods 0.000 title claims abstract description 29
- 238000000746 purification Methods 0.000 title claims abstract description 18
- 150000001875 compounds Chemical class 0.000 claims abstract description 62
- 238000004366 reverse phase liquid chromatography Methods 0.000 claims abstract description 21
- 239000000126 substance Substances 0.000 claims abstract description 14
- 238000004808 supercritical fluid chromatography Methods 0.000 claims abstract description 10
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 114
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical group CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 45
- 241000544066 Stevia Species 0.000 claims description 39
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 claims description 39
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 35
- 239000012452 mother liquor Substances 0.000 claims description 29
- 230000005526 G1 to G0 transition Effects 0.000 claims description 19
- 238000010828 elution Methods 0.000 claims description 11
- 239000000463 material Substances 0.000 claims description 10
- 239000007788 liquid Substances 0.000 claims description 8
- 239000012043 crude product Substances 0.000 claims description 5
- 235000003599 food sweetener Nutrition 0.000 claims description 4
- 239000003607 modifier Substances 0.000 claims description 4
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 4
- 239000003765 sweetening agent Substances 0.000 claims description 4
- 239000002904 solvent Substances 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 2
- 238000005191 phase separation Methods 0.000 claims 4
- 235000007516 Chrysanthemum Nutrition 0.000 claims 1
- 240000005250 Chrysanthemum indicum Species 0.000 claims 1
- 238000005406 washing Methods 0.000 claims 1
- 238000003919 heteronuclear multiple bond coherence Methods 0.000 description 9
- 239000000203 mixture Substances 0.000 description 9
- 238000010586 diagram Methods 0.000 description 7
- -1 diterpene glycosides Chemical class 0.000 description 7
- 238000003929 heteronuclear multiple quantum coherence Methods 0.000 description 7
- 238000001514 detection method Methods 0.000 description 6
- 238000013375 chromatographic separation Methods 0.000 description 5
- 238000011161 development Methods 0.000 description 5
- 238000010829 isocratic elution Methods 0.000 description 5
- 238000001953 recrystallisation Methods 0.000 description 5
- 238000001228 spectrum Methods 0.000 description 5
- 238000005481 NMR spectroscopy Methods 0.000 description 4
- 238000002330 electrospray ionisation mass spectrometry Methods 0.000 description 4
- 238000001460 carbon-13 nuclear magnetic resonance spectrum Methods 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 238000004896 high resolution mass spectrometry Methods 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- PIWMSRFXAJSGLP-UHFFFAOYSA-N oxane-3,4-diol Chemical compound OC1CCOCC1O PIWMSRFXAJSGLP-UHFFFAOYSA-N 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 241000208838 Asteraceae Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 239000004383 Steviol glycoside Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 229930004069 diterpene Natural products 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 238000001052 heteronuclear multiple bond coherence spectrum Methods 0.000 description 1
- 208000021822 hypotensive Diseases 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 235000014594 pastries Nutrition 0.000 description 1
- 150000007965 phenolic acids Chemical class 0.000 description 1
- 235000009048 phenolic acids Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 229930182488 steviol glycoside Natural products 0.000 description 1
- 235000019411 steviol glycoside Nutrition 0.000 description 1
- 150000008144 steviol glycosides Chemical class 0.000 description 1
- 235000019202 steviosides Nutrition 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/94—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom spiro-condensed with carbocyclic rings or ring systems, e.g. griseofulvins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D301/00—Preparation of oxiranes
- C07D301/32—Separation; Purification
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
- C07D303/02—Compounds containing oxirane rings
- C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
- C07D303/32—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by aldehydo- or ketonic radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
- C07H1/06—Separation; Purification
- C07H1/08—Separation; Purification from natural products
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
- C07H15/203—Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/54—Improvements relating to the production of bulk chemicals using solvents, e.g. supercritical solvents or ionic liquids
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Saccharide Compounds (AREA)
Abstract
Description
技术领域technical field
本发明涉及天然产物分离纯化领域,尤其涉及从一种甜叶菊的分离纯化方法及获得的甜叶菊基础物质。The invention relates to the field of separation and purification of natural products, in particular to a method for separation and purification of stevia rebaudiana and the obtained stevia rebaudiana base material.
背景技术Background technique
甜叶菊(Stevia rebaudianaBertoni,S.rebaudiana),又名甜菊叶,系菊科甜叶菊属多年生植物。甜叶菊原产于南美巴拉圭的东北高地,1977年,我国从日本引进甜叶菊并进行大规模种植。由于甜叶菊中的二萜糖苷类物质具有高甜度、不易被吸收,低热量的特点,所以甜叶菊是一种理想的甜味剂,可用于预防肥胖症和糖尿病。除了作为甜味剂,药理研究表明甜叶菊具有抗氧化、抗肿瘤、抗炎、降血压、抑菌和抗病毒等诸多活性。为了进一步阐明甜叶菊的药理作用,对其物质基础进行研究至关重要。Stevia (Stevia rebaudiana Bertoni, S.rebaudiana), also known as stevia leaves, is a perennial plant of the genus Stevia in the family Asteraceae. Stevia is native to the northeast highlands of Paraguay in South America. In 1977, my country introduced stevia from Japan and planted it on a large scale. Because the diterpene glycosides in Stevia rebaudiana have the characteristics of high sweetness, not easy to be absorbed, and low calorie, so Stevia rebaudiana is an ideal sweetener, which can be used to prevent obesity and diabetes. In addition to being a sweetener, pharmacological studies have shown that stevia has many activities such as antioxidant, anti-tumor, anti-inflammatory, hypotensive, antibacterial and antiviral. In order to further clarify the pharmacological effects of stevia, it is very important to study its material basis.
甜叶菊物质基础研究主要基于对其化学成分的分离,目前,已知的甜叶菊中的化学成分包括甜菊糖苷类、黄酮类、酚酸类和挥发油等。由于甜叶菊组成复杂,不同种类成分含量差别大,同类成分结构相似,增大了分离难度。基于现代分离技术开展系统的分离纯化工作,对于进一步了解甜叶菊的化学组成,开发利用甜叶菊资源有重要的意义。The research on the material basis of stevia is mainly based on the separation of its chemical components. At present, the known chemical components in stevia include steviol glycosides, flavonoids, phenolic acids and volatile oils. Due to the complex composition of Stevia rebaudiana, the content of different types of components varies greatly, and the structure of similar components is similar, which increases the difficulty of separation. Carrying out systematic separation and purification work based on modern separation technology is of great significance for further understanding of the chemical composition of stevia rebaudiana and the development and utilization of stevia rebaudiana resources.
发明内容Contents of the invention
本发明的目的是提供一种甜叶菊的分离纯化方法,用于分离提取甜叶菊中的化合物,以为甜叶菊的开发提供基础。通过本申请所述分离纯化方法获得了4种新的化合物,可以用于甜叶菊的物质基础研,进而期待在在食品行业或医药行业中获得应用。The object of the present invention is to provide a method for separation and purification of stevia, which is used for separating and extracting compounds in stevia, so as to provide a basis for the development of stevia. Four new compounds were obtained through the separation and purification method described in this application, which can be used in the basic research of stevia rebaudiana, and are expected to be applied in the food industry or the pharmaceutical industry.
根据本发明的一方面,提供一种甜叶菊的分离纯化方法。所述甜叶菊的分离纯化方法是对甜叶菊进行反相色谱、超临界流体色谱分离纯化,以提取甜叶菊基础物质。According to one aspect of the present invention, a method for separating and purifying Stevia is provided. The separation and purification method of stevia is to perform reverse phase chromatography and supercritical fluid chromatography to separate and purify stevia to extract the basic substance of stevia.
在一些实施例中,所述甜叶菊的分离纯化方法包括步骤:以重结晶法处理甜叶菊母液糖,获得母液糖粗品;对所述母液糖粗品进行反相色谱分离,以获得多个粗组分;对粗组分进行超临界流体色谱分离,以获得多个精细组分;以及,对精细组分进行反相色谱分离,以获得甜叶菊基础物质。In some embodiments, the method for separating and purifying stevia rebaudiana comprises the steps of: treating stevia mother liquor sugar with recrystallization method to obtain crude mother liquor sugar; performing reverse-phase chromatography on the mother liquor crude sugar to obtain multiple crude groups separation; performing supercritical fluid chromatography separation on the coarse component to obtain multiple fine components; and performing reverse phase chromatography separation on the fine component to obtain the stevia base material.
在一些实施例中,在所述重结晶处理甜叶菊母液糖的步骤中,以无水甲醇作为溶剂对所述甜叶菊母液糖进行重结晶。In some embodiments, in the step of recrystallizing the stevia mother liquor, anhydrous methanol is used as a solvent to recrystallize the stevia mother liquor.
在一些实施例中,所述甜叶菊母液糖与所述无水甲醇的料液比为:每1升无水甲醇中加入120g甜叶菊母液糖。In some embodiments, the solid-liquid ratio of the stevia mother liquor to the anhydrous methanol is: 120 g of stevia mother liquor is added to 1 liter of anhydrous methanol.
在一些实施例中,在所述反相色谱分离步骤中,采用十八烷基键合固定相进行分离;流动相为甲醇与水,或者乙腈与水。In some embodiments, in the reversed-phase chromatographic separation step, an octadecyl bonded stationary phase is used for separation; the mobile phase is methanol and water, or acetonitrile and water.
在一些实施例中,在对粗组分进行超临界流体色谱分离的步骤中,固定相为C4,流动相为超临界CO2,甲醇为改性剂,梯度洗脱。In some embodiments, in the step of separating crude components by supercritical fluid chromatography, the stationary phase is C4, the mobile phase is supercritical CO 2 , methanol is a modifier, and gradient elution is performed.
在一些实施例中,所述甜叶菊基础物质具有以下式i-1至i-4所示的结构:In some embodiments, the stevia base material has the structures shown in the following formulas i-1 to i-4:
其中,上述化合物的命名为:Wherein, the name of above-mentioned compound is:
式i-1:2,7,10,10-tetramethyl-1-oxaspiro[4.5]deca-3,6-dien-8-one;Formula i-1: 2,7,10,10-tetramethyl-1-oxaspiro[4.5]deca-3,6-dien-8-one;
式i-2:Formula i-2:
(E)-4-(7-hydroxy-5-(hydroxymethyl)-1a,2a,5-trimethyldecahydronaphtho[2,3-b]oxiren-2-yl)but-3-en-2-one;(E)-4-(7-hydroxy-5-(hydroxymethyl)-1a,2a,5-trimethyldecahydronaphtho[2,3-b]oxiren-2-yl)but-3-en-2-one;
式i-3:Formula i-3:
5-((4,5-dihydroxy-6-(hydroxymethyl)-2-((3,4,5,6-tetrahydroxytetrahydro-2H-pyran-2-yl)methoxy)tetrahydro-2H-pyran-3-yl)oxy)-5,7,7-trimethyl-4,5,6,7-tetrahydro-1H-inden-1-one;5-((4,5-dihydroxy-6-(hydroxymethyl)-2-((3,4,5,6-tetrahydroxytetrahydro-2H-pyran-2-yl)methoxy)tetrahydro-2H-pyran-3-yl) oxy)-5,7,7-trimethyl-4,5,6,7-tetrahydro-1H-inden-1-one;
式i-4:6-(4-allyl-2-methoxyphenoxy)-5-amino-2-(hydroxymethyl)tetrahydro-2H-pyran-3,4-diol(i-4)Formula i-4: 6-(4-allyl-2-methoxyphenoxy)-5-amino-2-(hydroxymethyl)tetrahydro-2H-pyran-3,4-diol(i-4)
在一些实施例中,所述甜叶菊中化合分离纯化方法具体包括以下步骤:In some embodiments, the compound separation and purification method in Stevia rebaudiana specifically includes the following steps:
步骤1采取重结晶法处理甜叶菊母液糖,称取甜叶菊母液糖置于干燥洁净的容器,加入无水甲醇,超声搅拌溶解,室温下静置24h,过滤后得母液糖粗品。Step 1: adopt the recrystallization method to process the mother liquor of stevia rebaudiana, weigh the mother liquor of stevia rebaudiana, put it in a dry and clean container, add anhydrous methanol, stir and dissolve it ultrasonically, let it stand at room temperature for 24 hours, and obtain the crude sugar of mother liquor after filtration.
步骤2将母液糖粗品用纯水溶解,采用反相色谱法,使用C18固定相分离,甲醇和水为流动相,台阶梯度条件洗脱,收集三段组分,依次记作Fr.1-Fr.3。
步骤3将Fr.1以纯甲醇溶解,采用超临界流体色谱分离,固定相为C4,流动相为超临界CO2,甲醇为改性剂,梯度洗脱。按峰收集,得到5个组分,记作Fr.1-1~Fr.1-5。In
步骤4将Fr.1-1用纯水溶解,采用反相色谱法,使用C18固定相分离,流动相是甲醇和水,30%甲醇等度洗脱,得到化合物i-1。
步骤5将Fr.1-2用纯水溶解,采用反相色谱法,使用C18固定相分离,流动相是甲醇和水,45%甲醇等度洗脱,得到化合物i-2和Fr.1-2-1。
步骤6将Fr.1-3用纯水溶解,采用反相色谱法,使用C18固定相分离,流动相是乙腈和水,18%乙腈等度洗脱,得到化合物i-3。
步骤7将Fr.1-2-1用纯水溶解,采用反相色谱法,使用C18固定相分离,流动相是乙腈和水,28%乙腈等度洗脱,得到化合物i-4。
甜叶菊作为甜味剂被广泛用于饮品、奶制品、糕点和糖果等食品行业。同时,甜叶菊具有多种药理活性,在新药开发方面有一定的前景。因此,基于本申请的分离纯化方法发现的甜叶菊中的上述新化合物,能够对深入了解甜叶菊化学组成,开发利用甜叶菊资源有重要意义。Stevia is widely used as a sweetener in food industries such as beverages, dairy products, pastries and candies. At the same time, stevia has a variety of pharmacological activities, and has certain prospects in the development of new drugs. Therefore, the above-mentioned new compounds in Stevia rebaudiana discovered based on the separation and purification method of the present application are of great significance for in-depth understanding of the chemical composition of Stevia rebaudiana and the development and utilization of stevia rebaudiana resources.
在本发明中,对经重结晶的甜叶菊母液进行反相色谱分离纯化,以获得了4种未记载的化合物,并进一步采用1H NMR、13C NMR、二维核磁谱、高分辨质谱对获得的化合物,进行结构鉴定,推导出了化合物的分子结构,为甜叶菊的质量控制和商业开发提供一定的物质基础。In the present invention, the recrystallized Stevia rebaudiana mother liquor was separated and purified by reverse phase chromatography to obtain 4 unrecorded compounds, which were further analyzed by 1 H NMR, 13 C NMR, two-dimensional nuclear magnetic spectrum, and high-resolution mass spectrometry. The obtained compound was identified through structural identification, and the molecular structure of the compound was deduced to provide a certain material basis for the quality control and commercial development of stevia.
附图说明Description of drawings
图1母液糖粗品的反相制备色谱分离;The reverse phase preparation chromatographic separation of Fig. 1 mother liquor sugar crude product;
图2Fr.1的超临界流体色谱制备图;The supercritical fluid chromatography preparation diagram of Fig. 2Fr.1;
图3Fr.1-1~Fr.1-3反相制备图;Figure 3 Fr.1-1 ~ Fr.1-3 reverse phase preparation diagram;
图4化合物i-1的1HNMR图;The 1 HNMR figure of Fig. 4 compound i-1;
图5化合物i-1的13CNMR图;The 13 CNMR figure of Fig. 5 compound i-1;
图6化合物i-1的COSY图;Figure 6 COZY diagram of compound i-1;
图7化合物i-1的HMQC图;The HMQC figure of Fig. 7 compound i-1;
图8化合物i-1的HMBC图;The HMBC figure of Fig. 8 compound i-1;
图9化合物i-2的1HNMR图;The 1 HNMR figure of Fig. 9 compound i-2;
图10化合物i-2的13CNMR图;The 13 CNMR figure of Fig. 10 compound i-2;
图11化合物i-2的COSY图;Figure 11 COZY diagram of compound i-2;
图12化合物i-2的HMQC图;The HMQC figure of Fig. 12 compound i-2;
图13化合物i-2的HMBC图;The HMBC figure of Fig. 13 compound i-2;
图14化合物i-2的NOESY图Figure 14 NOESY plot of compound i-2
图15化合物i-3的1HNMR图;The 1 HNMR figure of Fig. 15 compound i-3;
图16化合物i-3的13CNMR图; 13 CNMR figure of Fig. 16 compound i-3;
图17化合物i-3的COSY图;Figure 17 COZY diagram of compound i-3;
图18化合物i-3的HMQC图;The HMQC figure of Fig. 18 compound i-3;
图19化合物i-3的HMBC图1(化学位移δ1.0~7.6);Figure 19 HMBC Figure 1 of compound i-3 (chemical shift δ1.0~7.6);
图20化合物i-3的HMBC图2(化学位移δ3.1~4.6);Figure 20 HMBC Figure 2 of compound i-3 (chemical shift δ3.1-4.6);
图21化合物i-3的HMBC图3(化学位移δ0.9~2.6);Figure 21 HMBC Figure 3 of compound i-3 (chemical shift δ0.9~2.6);
图22化合物i-4的1HNMR图;The 1 HNMR figure of Fig. 22 compound i-4;
图23化合物i-4的13CNMR图; 13 CNMR figure of Fig. 23 compound i-4;
图24化合物i-4的COSY图;Figure 24 COZY diagram of compound i-4;
图25化合物i-4的HMQC图;The HMQC figure of Fig. 25 compound i-4;
图26化合物i-4的HMBC图1(化学位移δ3.0~7.4);Figure 26 HMBC Figure 1 of compound i-4 (chemical shift δ3.0~7.4);
图27化合物i-4的HMBC图2(化学位移δ3.2~4.1)。Fig. 27 HMBC diagram 2 of compound i-4 (chemical shift δ3.2-4.1).
具体实施方式Detailed ways
下面将结合本发明实施例中的附图,对本发明实施例中的技术方案进行清楚、完整地描述。The following will clearly and completely describe the technical solutions in the embodiments of the present invention with reference to the drawings in the embodiments of the present invention.
实施例1.甜叶菊中四个化合物分离纯化方法Example 1. Four compound separation and purification methods in Stevia rebaudiana
在本实施例中,提供一种甜叶菊的分离纯化方法,包括步骤:以重结晶法处理甜叶菊母液糖,获得母液糖粗品;对所述母液糖粗品进行反相色谱分离,以获得多个粗组分;对粗组分进行超临界流体色谱分离,以获得多个精细组分;以及,对精细组分进行反相色谱分离,以获得甜叶菊基础物质。In this embodiment, a separation and purification method of Stevia rebaudiana is provided, comprising the steps of: treating the mother liquor sugar with recrystallization method to obtain a crude mother liquor sugar; performing reverse-phase chromatographic separation on the mother liquor sugar crude product to obtain multiple Coarse fractions; performing supercritical fluid chromatography on the coarse fractions to obtain a plurality of fine fractions; and performing reversed-phase chromatography on the fine fractions to obtain the stevia base material.
具体地,在本实施例中,所述甜叶菊中化合分离纯化方法包括步骤:Specifically, in this embodiment, the method for separating and purifying compounds in Stevia rebaudiana includes the steps of:
以重结晶法处理甜叶菊母液糖的步骤Steps of processing stevia mother liquor sugar by recrystallization method
以无水甲醇作为溶剂对所述甜叶菊母液糖进行重结晶,获得母液糖粗品;其中,所述甜叶菊母液糖与所述无水甲醇的料液比为:每1升无水甲醇中加入120g甜叶菊母液糖;Using anhydrous methanol as a solvent to recrystallize the stevia mother liquor sugar to obtain a crude mother liquor sugar; wherein, the solid-liquid ratio of the stevia mother liquor sugar to the anhydrous methanol is: every 1 liter of anhydrous methanol is added 120g stevia mother liquid sugar;
对所述母液糖粗品进行反相色谱分离的步骤Carrying out the step of reverse phase chromatographic separation to described mother liquid sugar crude product
采用十八烷基键合固定相进行分离,甲醇和水为流动相,台阶梯度条件洗脱,以获得多个粗组分;Octadecyl bonded stationary phase is used for separation, methanol and water are used as mobile phase, and step gradient conditions are used for elution to obtain multiple crude components;
对粗组分进行超临界流体色谱分离的步骤Steps for Supercritical Fluid Chromatography Separation of Crude Components
固定相为C4,流动相为超临界CO2,甲醇为改性剂,梯度洗脱,按峰收集以获得多个精细组分;以及,The stationary phase is C4, the mobile phase is supercritical CO 2 , methanol is used as a modifier, and gradient elution is performed, collecting by peaks to obtain multiple fine components; and,
对精细组分进行反相色谱分离的步骤Procedure for Reversed-Phase Chromatographic Separation of Fine Components
采用十八烷基键合固定相进行分离,流动相为甲醇与水或者乙腈与水,以30%~45%甲醇或15%~30%乙腈等度洗脱,以获得甜叶菊基础物质。The octadecyl bonded stationary phase is used for separation, the mobile phase is methanol and water or acetonitrile and water, and isocratic elution is performed with 30% to 45% methanol or 15% to 30% acetonitrile to obtain the basic substance of stevia rebaudiana.
在本实施例中,具体以20g甜叶菊母液糖为例,进行分离纯化,具体步骤如下:In this embodiment, 20g of stevia mother liquid sugar is specifically taken as an example to carry out separation and purification, and the specific steps are as follows:
步骤1重结晶法处理甜叶菊母液糖:准确称取20g甜叶菊母液糖置于干燥洁净的容器,按照料液比(w/v,g/L)120:1加入无水甲醇,超声搅拌溶解,室温下静置24h,过滤,滤液冻干得母液糖粗品。共处理300g母液糖,得到135g冻干粉末。
步骤2用纯水溶解母液糖粗品,超声辅助溶解,配置成浓度为400mg/mL样品溶液。取C18填料(60μm)300g,乙醇匀浆装于50mm DAC柱,测量柱长高度为250mm;流动相组成:A为水,B为甲醇;洗脱方式:0-15min,60%B;15.01-30min,80%B;30.01-40min,100%B;进样体积:20mL;流速:70.0mL/min。柱温:室温;检测波长227nm。得到三段组分Fr.1(6.37g)、Fr.2(103.80g)和Fr.3(3.22g),色谱图见图1。在本实施例中,取组分Fr.1为例进行进一步的说明。本领域技术人员可以理解的是,对于组分Fr.2和Fr.3也可以采用相同的后续处理步骤。
步骤3以纯甲醇溶解组分Fr.1,浓度为70mg/mL。使用色谱柱Unitary C4(250×20mm,i.d.,5μm)分离,流动相组成:A为CO2,B为甲醇;洗脱方式:0-4.2min,15-30%B,流速52mL/min;4.2-5.2min,30-50%B,流速52-40mL/min;5.2-10min,50%B,流速40mL/min;背压130bar;进样体积:1mL;柱温:25℃;检测波长227nm。按峰收集,得到5个组分,记作Fr.1-1-Fr.1-5,色谱图见图2。在本实施例中,取组分Fr.1-1至Fr.1-3为例进行进一步的说明。本领域技术人员可以理解的是,对于组分Fr.1-4和Fr.1-5也可以采用相同的后续处理步骤。
步骤4将Fr.1-1用纯水溶解,使用色谱柱C18(250×20mm i.d.,10μm)分离。流动相组成:水和甲醇,流速:19mL/min,柱温:室温,检测波长227nm。0-23min,30%甲醇洗脱,得化合物i-1(4.05mg),色谱图见图3a。
步骤5将Fr.1-2用纯水溶解,使用色谱柱C18(250×20mm i.d.,10μm)分离。流动相组成:水和甲醇,流速:19mL/min,柱温:室温,检测波长227nm。0-27min,45%甲醇洗脱,得化合物i-2(3.86mg)和组分Fr.1-2-1,色谱图见图3b。
步骤6将Fr.1-3用纯水溶解,使用色谱柱C18(250×20mm i.d.,10μm)分离。流动相组成:水和乙腈,流速:19mL/min,柱温:室温,检测波长227nm。0-25min,18%乙腈洗脱,得化合物i-3(2.23mg),色谱图见图3c。Step 6: Dissolve Fr.1-3 in pure water and separate using chromatographic column C18 (250×20 mm i.d., 10 μm). Mobile phase composition: water and acetonitrile, flow rate: 19mL/min, column temperature: room temperature, detection wavelength 227nm. 0-25 min, eluted with 18% acetonitrile to obtain compound i-3 (2.23 mg), the chromatogram is shown in Figure 3c.
步骤7将Fr.1-2-1用纯水溶解,使用色谱柱C18(250×20mm i.d.,10μm)分离。流动相组成:水和乙腈,流速:19mL/min,柱温:室温,检测波长227nm。0-12min,28%乙腈洗脱,得到化合物i-4(6.24mg),色谱图见图3d。
实施例2.甜叶菊中四个化合物鉴定Example 2. Identification of four compounds in Stevia rebaudiana
在本实施例中,提供实施例1中制备的甜叶菊中四个单体化合物的鉴定方法,采用现代波谱技术如1H NMR、13C NMR、二维核磁谱、高分辨质谱,对实施例1中得到的四个单体化合物进行结构鉴定。In this example, the identification method of the four monomeric compounds in Stevia rebaudiana prepared in Example 1 is provided, using modern spectral techniques such as 1 H NMR, 13 C NMR, two-dimensional nuclear magnetic spectrum, and high-resolution mass spectrometry. The structures of the four monomeric compounds obtained in 1 were identified.
化合物i-1:ESI-MS m/z:207.14[M+H]+,分子式C13H18O2。结合1H-NMR谱图(图4)、13C-NMR谱图(图5)、COSY谱图(图6)、HMQC谱图(图7)和HMBC谱图(图8)确定化合物i-1为:2,7,10,10-tetramethyl-1-oxaspiro[4.5]deca-3,6-dien-8-one。Compound i-1: ESI-MS m/z: 207.14[M+H] + , molecular formula C 13 H 18 O 2 . Compound i- 1 is: 2,7,10,10-tetramethyl-1-oxaspiro[4.5]deca-3,6-dien-8-one.
化合物i-2:ESI-MS m/z:309.20[M+H]+,分子式C18H28O4。通过1H-NMR谱图(图9)、13C-NMR谱图(图10)、COSY谱图(图11)、HMQC谱图(图12)、HMBC谱图(图13)及NOESY谱图(图14)确定化合物i-2为:Compound i-2: ESI-MS m/z: 309.20[M+H] + , molecular formula C 18 H 28 O 4 . Through 1 H-NMR spectrum (Figure 9), 13 C-NMR spectrum (Figure 10), COZY spectrum (Figure 11), HMQC spectrum (Figure 12), HMBC spectrum (Figure 13) and NOESY spectrum (Fig. 14) determine that compound i-2 is:
(E)-4-(7-hydroxy-5-(hydroxymethyl)-1a,2a,5-trimethyldecahydronaphtho[2,3-b]oxiren-2-yl)but-3-en-2-one。(E)-4-(7-hydroxy-5-(hydroxymethyl)-1a,2a,5-trimethyldecahydronaphtho[2,3-b]oxiren-2-yl)but-3-en-2-one.
化合物i-3:ESI-MS m/z:517.27[M+H]+,分子式C24H36O12,结合1H-NMR谱图(图15)、13C-NMR谱图(图16)、COSY谱图(图17)、HMQC谱图(图18)和HMBC谱图(图19-图21)确定化合物i-3为:Compound i-3: ESI-MS m/z: 517.27[M+H] + , molecular formula C 24 H 36 O 12 , combined with 1 H-NMR spectrum (Figure 15), 13 C-NMR spectrum (Figure 16) , COZY spectrogram (Fig. 17), HMQC spectrogram (Fig. 18) and HMBC spectrogram (Fig. 19-Fig. 21) determine that compound i-3 is:
5-((4,5-dihydroxy-6-(hydroxymethyl)-2-((3,4,5,6-tetrahydroxytetrahydro-2H-pyran-2-yl)methoxy)tetrahydro-2H-pyran-3-yl)oxy)-5,7,7-trimethyl-4,5,6,7-tetrahydro-1H-inden-1-one。5-((4,5-dihydroxy-6-(hydroxymethyl)-2-((3,4,5,6-tetrahydroxytetrahydro-2H-pyran-2-yl)methoxy)tetrahydro-2H-pyran-3-yl) oxy)-5,7,7-trimethyl-4,5,6,7-tetrahydro-1H-inden-1-one.
化合物i-4:ESI-MS m/z:344.17[M+H+H2O]+,分子式C16H23NO6,结合1H-NMR谱图(图22)、13C-NMR谱图(图23)、COSY谱图(图24)、HMQC谱图(图25)和HMBC谱图谱图(图26和图27)确定化合物i-4为:Compound i-4: ESI-MS m/z: 344.17[M+H+H 2 O] + , molecular formula C 16 H 23 NO 6 , combined with 1 H-NMR spectrum (Figure 22), 13 C-NMR spectrum (Fig. 23), COZY spectrogram (Fig. 24), HMQC spectrogram (Fig. 25) and HMBC spectrogram (Fig. 26 and Fig. 27) determine that compound i-4 is:
6-(4-allyl-2-methoxyphenoxy)-5-amino-2-(hydroxymethyl)tetrahydro-2H-pyran-3,4-diol。6-(4-allyl-2-methoxyphenoxy)-5-amino-2-(hydroxymethyl)tetrahydro-2H-pyran-3,4-diol.
尽管参照前述实施例对本发明进行了详细的说明,对于本领域的技术人员来说,其依然可以对前述各实施例所记载的技术方案进行修改,或者对其中部分技术特征进行等同替换,凡在本发明的精神和原则之内,所作的任何修改、等同替换、改进等,均应包含在本发明的保护范围之内。Although the present invention has been described in detail with reference to the aforementioned embodiments, those skilled in the art can still modify the technical solutions described in the aforementioned embodiments, or perform equivalent replacements for some of the technical features. Within the spirit and principles of the present invention, any modifications, equivalent replacements, improvements, etc., shall be included in the protection scope of the present invention.
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011219059.1A CN112724112B (en) | 2020-11-04 | 2020-11-04 | Separation and purification method of stevia rebaudiana |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011219059.1A CN112724112B (en) | 2020-11-04 | 2020-11-04 | Separation and purification method of stevia rebaudiana |
Publications (2)
Publication Number | Publication Date |
---|---|
CN112724112A CN112724112A (en) | 2021-04-30 |
CN112724112B true CN112724112B (en) | 2023-03-14 |
Family
ID=75597373
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202011219059.1A Active CN112724112B (en) | 2020-11-04 | 2020-11-04 | Separation and purification method of stevia rebaudiana |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112724112B (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101801177A (en) * | 2007-08-01 | 2010-08-11 | 吉百利控股有限公司 | sweetener compositions |
CN108473528A (en) * | 2015-10-29 | 2018-08-31 | 赛诺米克斯公司 | High intensity sweetner |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8728545B2 (en) * | 2010-07-16 | 2014-05-20 | Justbio Inc. | Extraction method for providing an organic certifiable Stevia rebaudiana extract |
-
2020
- 2020-11-04 CN CN202011219059.1A patent/CN112724112B/en active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101801177A (en) * | 2007-08-01 | 2010-08-11 | 吉百利控股有限公司 | sweetener compositions |
CN108473528A (en) * | 2015-10-29 | 2018-08-31 | 赛诺米克斯公司 | High intensity sweetner |
Non-Patent Citations (6)
Title |
---|
Antiplasmodial decarboxyportentol acetate and 3,4-dehydrotheaspirone from Laumoniera bruceadelpha;Hiroshi Morita et al.;《J Nat Med》;20120103;第66卷;第572页 * |
Biocatalytic Synthesis of Non-Natural Monoterpene O-Glycosides Exhibiting Superior Antibacterial and Antinematodal Properties;Puspalata Bashyal et al.;《ACS Omega》;20190529;第4卷;第9368页 * |
Hiroshi Morita et al..Antiplasmodial decarboxyportentol acetate and 3,4-dehydrotheaspirone from Laumoniera bruceadelpha.《J Nat Med》.2012,第66卷第571-575页. * |
Puspalata Bashyal et al..Biocatalytic Synthesis of Non-Natural Monoterpene O-Glycosides Exhibiting Superior Antibacterial and Antinematodal Properties.《ACS Omega》.2019,第4卷第9367-9375页. * |
甜叶菊化学成分及其甜度的研究;杨全花 等;《北京化工大学学报(自然科学版)》;20121231;第39卷(第2期);第29页 * |
离线二维反相液相色谱/超临界流体色谱在瓜蒌子分离中的应用;袁云 等;《色谱》;20170731;第35卷(第7期);第684页 * |
Also Published As
Publication number | Publication date |
---|---|
CN112724112A (en) | 2021-04-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2769512C2 (en) | Method for isolating eight compounds from composition based on chinese medicine drugs | |
CN110452249B (en) | New gemmarane-type sesquiterpene lactones and their preparation and application | |
CN107459477B (en) | A kind of isoindole alkaloid compound in purslane and its extraction and separation method | |
Xie et al. | Separation and purification of echinacoside from Penstemon barbatus (Can.) Roth by recycling high-speed counter-current chromatography | |
CN106278829A (en) | Honokiol derivative, preparation and separation method and application thereof | |
CN104327127B (en) | Method for preparing angroside C, aucubin and harpagide through separation and purification by high-speed countercurrent chromatography | |
JP7305870B2 (en) | Method for producing tetragalloyl glucose | |
CN111533772B (en) | Preparation method of iridoid compound, iridoid compound and application | |
CN108484428B (en) | A kind of amide compound and amide compound component in wolfberry and preparation method thereof | |
CN112724112B (en) | Separation and purification method of stevia rebaudiana | |
CN114213473A (en) | Three kinds of alkaloids in purslane and their extraction and separation methods | |
KR101080648B1 (en) | A method for isolating and producing highly-concentrated Eupatilin and Jaceosidine from the extract of Artemisia species by using Centrifugal Partition Chromatography | |
CN113264886A (en) | Extraction and separation method and application of pyridazine compound in purslane | |
CN110028535B (en) | Diterpene glycoside compounds in longtube ground ivy herb and extraction and separation method thereof | |
CN104557471A (en) | Method for simultaneously preparing gram-grade high-purity tyrosol, renulatin and salidroside from rhodiola crenulata | |
CN114989084A (en) | Extraction and separation method of a tetrahydroisoquinoline alkaloid in purslane and its application | |
CN110294733B (en) | A compound Oleracone I containing peroxy bond in purslane and its extraction and separation method and application | |
CN115521245A (en) | Alkaloid compound in purslane and extraction and separation method and application thereof | |
CN108478619B (en) | Convolvulus arvensis total resin glucoside extract, preparation method and medical application thereof | |
CN109879926B (en) | Triterpene glycoside compounds in Glechomae herba and extraction and separation method thereof | |
CN113698446A (en) | Alkaloid compound in purslane and extraction and separation method thereof | |
CN106187710A (en) | Honokiol dimer and preparative separation method thereof and purposes | |
CN103896999B (en) | The preparation method of the gloomy glycosides reference substance of Bali | |
CN113968817B (en) | Extraction and separation method of two tetrahydroisoquinolines in purslane and application thereof | |
Hung et al. | Flavonoids and phenolics from the wholeplant of Macrosolen bidoupensis Tangane & VS Dang |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |